Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... और पढ़ें
U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07734662) titled 'High-Intensity vs. Preferred-Intensity Resistance Training in Fibromyalgia' on July 21. Br... और पढ़ें
Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and ... और पढ़ें
U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07733154) titled 'AI-Driven IOL Prediction Using SS-OCT Biometry' on July 23. Brief Summary: This prospectiv... और पढ़ें
Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and ... और पढ़ें
Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascim... और पढ़ें
Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with... और पढ़ें
U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07733869) titled 'The Addition of Core Muscle Training on Tennis Serve Speed in Tennis Players' on July 21. ... और पढ़ें
Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy ... और पढ़ें
Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitaxe... और पढ़ें